ROR1 is a novel putative druggable target for diffuse glioma
Ford, C.; John, M.; Rao, P.; Noor, H.
Show abstract
The cell surface receptor ROR1 is a therapeutic target of growing interest in oncology; however, its role in glioma has not been established thus far. This study analyzed associations between ROR1 mRNA expression and clinical outcomes, and histological and molecular subtypes in four independent glioma (grades II-IV) transcriptomic datasets (The Cancer Genome Atlas-GBMLGG, Chinese Glioma Genome Atlas, Repository for Molecular Brain Neoplasia, and GSE16011), encompassing a total of 2,388 cases. The data strongly suggests that ROR1 may be associated with poorer outcomes and more aggressive disease. Taken together, ROR1 should be further examined as a novel putative druggable target for glioma, a cancer that currently has very limited therapeutic options.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- miR-644a is a tumor cell-intrinsic mediator of sex bias in glioblastoma 94%
- Tumor Mutational Burden Predicts Survival In Patients With Low Grade Gliomas Expressing Mutated IDH1 93%
- Tumor Edge-to-Core Transition Promotes Malignancy in Primary-to-Recurrent Glioblastoma Progression in a PLAGL1/CD109-mediated mechanism 93%
Similar papers in this journal
- Disrupting Akt-Wnt/β-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice 94%
- Transcription factors NFIA and NFIB induce cellular differentiation high-grade astrocytoma 91%
- Rapid DNA methylation-based classification of pediatric brain tumours from ultrasonic aspirate specimens 91%
Similar papers in this journal
- CD8+ T-cell-mediated immunoediting influences genomic evolution and immune evasion in murine gliomas 94%
- Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome 92%
- Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance 92%
Similar papers in this journal
- FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses 95%
- The impact of germline variants in DNA repair pathways on survival and temozolomide toxicity in adults with glioma 94%
- A subset of pediatric thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR 93%
Similar papers in this journal
- High Affinity Chimeric Antigen Receptor with Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms 92%
- Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in GBM 91%
- Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment with Standard-of-Care 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.